Elevage Medical Technologies logo

Elevage Medical Technologies

Description

Elevage Medical Technologies offers support and growth for medical device companies by provding capital and expertise.

Investor Profile

Elevage Medical Technologies has made 3 investments, with 3 in the past 12 months and 100% as lead.

Stage Focus

  • Series D (33%)
  • Series C (33%)
  • Series Unknown (33%)

Country Focus

  • United States (33%)
  • United Kingdom (33%)
  • Ireland (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Life Science
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Elevage Medical Technologies frequently co-invest with?

Warren Point Capital
North America, California, United States, Santa Barbara
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Vertex Ventures HC
North America, California, United States, Palo Alto
Co-Investments: 1
British Patient Capital
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Future Fund
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2

Which angels does Elevage Medical Technologies often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Elevage Medical Technologies?

FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Nuclera

Cambridge, Cambridgeshire, United Kingdom

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

BiotechnologyLife SciencePharmaceutical
Series COct 15, 2024
Amount Raised: $75,000,000
Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series DAug 13, 2024
Amount Raised: $61,000,000